Destiny Pharma welcomes the proposed PASTEUR Act in USA, with financial support ranging from $750 million to $3 billion, to launch new antiinfective products targeting life threatening infections.
Click on the link below for more information:-
Destiny Pharma welcomes the proposed PASTEUR Act in USA, with financial support ranging from $750 million to $3 billion, to launch new antiinfective products targeting life threatening infections.
Click on the link below for more information:-